Business Context and Reporting Period
This Form 8-K Current Report is filed by Eyenovia, Inc. (not Hyperion Defi, Inc.) on August 30, 2024, with the report dated September 3, 2024. The filing discloses significant changes in executive leadership, specifically the departure of the Chief Financial Officer and the appointment of a successor.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel changes and associated compensation arrangements.
Material Changes
- Departure of CFO: John Gandolfo retired effective August 30, 2024, from his roles as Chief Financial Officer, Treasurer, and Secretary.
- Transition Period: Mr. Gandolfo will remain an employee until November 30, 2024, to ensure a smooth transition, continuing to be compensated under his existing employment agreement.
- Appointment of New CFO: Andrew D. Jones was appointed Chief Financial Officer, Treasurer, and Secretary effective August 30, 2024.
Compensation, Outlook, and Risks
New Executive Compensation
Mr. Jones entered into an executive employment agreement with the following terms:
- Base Salary: $440,000 annually.
- Performance Bonus: Eligible for a cash bonus with an initial target of 40% of annual base salary, based on metrics determined by the Compensation Committee.
- Equity Award: Options to purchase 200,000 shares of common stock, vesting in four equal annual installments.
- Severance: In the event of a qualifying termination (without cause or involuntary), Mr. Jones is entitled to 12 months of base salary and up to 12 months of health insurance continuation.
Management Commentary and Risks
The filing notes that Mr. Jones brings significant experience from NovaBay Pharmaceuticals, MyoScience, and PricewaterhouseCoopers. There are no disclosed family relationships or undisclosed transactions between Mr. Jones and the Company. The filing includes a standard Regulation FD disclosure regarding a press release issued on September 3, 2024.
Investor Verification Checklist
- Verify the exact vesting schedule and exercise price of the 200,000 stock options granted to Mr. Jones in the attached Exhibit 10.1.
- Review the specific performance metrics for Mr. Jones' 40% target bonus, as they are to be determined by the Compensation Committee.
- Confirm the transition timeline for Mr. Gandolfo's responsibilities through November 30, 2024.
- Check the press release (Exhibit 99.1) for any additional context on the strategic reasons for the leadership change.